Elevance Health, Inc. (ELV)
| Market Cap | 99.88B |
| Revenue (ttm) | 176.81B |
| Net Income (ttm) | 5.98B |
| Shares Out | 226.39M |
| EPS (ttm) | 25.68 |
| PE Ratio | 17.18 |
| Forward PE | 12.78 |
| Dividend | $6.84 (1.55%) |
| Ex-Dividend Date | Mar 10, 2025 |
| Volume | 1,017,108 |
| Open | 439.68 |
| Previous Close | 439.81 |
| Day's Range | 435.35 - 443.21 |
| 52-Week Range | 362.21 - 567.26 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 531.90 (+20.57%) |
| Earnings Date | Apr 22, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for ELV stock is "Buy." The 12-month stock price forecast is $531.9, which is an increase of 20.57% from the latest price.
News
Which Stocks Stayed Green as the Market Plummeted?
Only a handful of S&P 500 stocks managed to generate gains during the market's historic four-day plunge.
GreensKeeper Q1 2025 Portfolio Update
Berkshire Hathaway led Q1 with a 17.5% return, driven by strong operating earnings and potential for significant acquisitions with over $300 billion in cash. Vertex Pharmaceuticals gained 20.4%, fuele...
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthca...
US Health Insurance Stocks Rally After $25 Billion Federal Boost To Medicare Payments
Health insurance stocks soared Tuesday morning on the first full day of trading after the U.S. government announced a more than 5% average increase in government reimbursement rates for 2026 Medicare ...
Humana and Other Health Insurance Stocks Surge on Higher-Than-Expected Medicare Payments
Shares of health insurance operators surged Tuesday after the government said it would pay a higher rate to Medicare insurers than previously estimated.
Health insurance stocks rise on 'best case scenario' Medicare payment rates
Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government's reimbursement rates for Medicare Advantage plans in 2026, bringing some relief to a sector bu...
Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath
Potato maker Lamb Weston Holdings Inc., telecom giant Verizon Communications Inc., drug maker AbbVie Inc. and retailer TJX Cos. all bucked a sharp market selloff Thursday, as Wall Street turned to sto...
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these...
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key fa...
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last art...
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, res...
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong r...
Elevance Health Bolsters Employer Insurance Business
Elevance Health says its acquisition of Verily's Granular Insurance Company is designed to bolster its offerings to self-funded employer clients. Financial terms of the deal aren't being disclosed, an...
Alphabet's Verily to sell Granular insurance business to Elevance Health
Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 with financial backing from the commercial insurance unit of the Swiss Re ...
Elevance Health Foundation Announces New Five-Year, $150 Million Commitment
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation today announces its new five-year, $150 million commitment aimed at addressing the physical, behavioral, and social needs of under-resourced c...
My Top 15 High-Growth Dividend Stocks For February 2025
The SPDR S&P 500 ETF Trust starts 2025 on a positive note gaining 2.67% in January. The Top 15 dividend growth stocks for February 2025 offer an average dividend yield of 1.64% and appear to be about ...
Trump gives a lift to healthcare stocks with comments on Medicare and Medicaid
Trump has pledged to protect Social Security and Medicare throughout his campaign, one analyst noted, but this was the first time he added Medicaid to the list.
Elevance Health, Inc. (ELV) Q4 2024 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q4 2024 Earnings Conference Call January 23, 2025 8:30 AM ET Company Participants Nathan Rich - VP, IR Gail Boudreaux - President & CEO Mark Kaye - CFO Felicia Norwoo...
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Shares of Elevance Health (ELV) advanced Thursday after the health insurance provider reported better-than-anticipated results on higher premiums, acquisitions, and growth of its pharmacy coverage uni...
GE Orders Soar, EA Slashes Guidance, ELV Ups Dividend
GE Aerospace (GE) jumped to levels it hasn't seen since 2007. The company posted an earnings beat and total orders that impressed investors.
Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
On Thursday, Elevance Health Inc. ELV reported fourth-quarter revenues of $44.99 billion, up 6% year-over-year, slightly higher than the consensus of $44.86 billion.
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Despite a 29% drop in Elevance Health's stock, I maintain a strong buy rating due to a DCF price target of $549.60, indicating 43% upside. ELV's shift towards managed care, with strong industry tailwi...
Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive.
The health insurer's fourth-quarter adjusted earnings top analysts' estimates.
Elevance Health earnings boost health-insurance stocks after upbeat outlook
UnitedHealth, Humana and Centene all rally premarket